Profile
AAPG VRTX REGN ALNY SGEN ARGX
Company Name Ascentage Pharma Group International Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc. Seagen Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $3.44B $117.98B $58.16B $43.28B $43.15B $34.40B
Employees 0.57K 6.10K 15.16K 2.23K 3.26K 1.60K
CEO Dajun Yang Reshma Kewalramani FASN, Leonard S. Schleifer Yvonne L. Greenstreet David R. Epstein Timothy Van Hauwermeiren EMBA,
Ratings
AAPG VRTX REGN ALNY SGEN ARGX
Quant Rating Score 1 2 4 1 3 2
Quant Rating Strong Sell Sell Buy Strong Sell Neutral Sell
Trading
AAPG VRTX REGN ALNY SGEN ARGX
Last Close $39.6201 $463.27 $550 $324.69 $228.74 $572.71
High 52 $42.85 $516.74 $1201.76 $331.91 $228.74 $671.75
Low 52 $17.2 $396.64 $482.92 $224.58 $228.74 $461.01
Price vs. 52 Week High -7.54 % -10.35 % -54.23 % -2.18 % 0 % -14.74 %
Price vs. 52 Week Low 130.35 % 16.8 % 13.89 % 44.58 % 0 % 24.23 %
Total Return
AAPG VRTX REGN ALNY SGEN ARGX
1 Month Return 10.42 % 3.32 % 7.09 % 3.96 % 0 % 6.47 %
3 Month Return 111.65 % -5.28 % -2.34 % 38.43 % 0 % -3.94 %
6 Month Return 0 % 9.78 % -19.31 % 31.84 % 0 % -10.59 %
9 Month Return 0 % -4.08 % -44.48 % 9.72 % 0 % 1.36 %
YTD Return 0 % 15.04 % -22.79 % 37.98 % 0 % -6.88 %
1 Year Return 0 % -5.09 % -48.47 % 37.17 % 0 % 22.75 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
AAPG VRTX REGN ALNY SGEN ARGX
Dividend Yield Percentage (TTM) - - 0.32 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -4.58 % -3.53 % 3.85 % -1.49 % -5.87 % -44.32 %
Dividend Per Share (TTM) - - 1.76 % - - -
Payout Ratio (TTM) - - 2.08 % - - -
Growth
AAPG VRTX REGN ALNY SGEN ARGX
Asset Growth 4.7 % -0.87 % 36.55 %
Gross Profit Growth 397.05 % 10.25 % 77.08 %
Revenue Growth 341.77 % 11.66 % 78.6 %
Revenue 3 Year 19001.13 % 45.6 % 275.84 %
Revenue 5 Year 2511.16 % 163.93 % 1701.04 %
Revenue 10 Year 8668.38 % 1632.15 % 5950.81 %
EBIT Growth 60.47 % -93.69 % 128.87 %
Net Income Growth 56.2 % -114.8 % 382.34 %
Net Income 3 Yeari Growth Per Share 56.32 % -122.89 % 274.39 %
Net Income 5 Yeari Growth Per Share 89.42 % -145.38 % 396.61 %
Net Income 10 Yeari Growth Per Share -157.74 % 33.84 % 938.02 %
Operating Income Growth 57.63 % -106.08 % 94.91 %
Operating Cash Flow Growth (CFG) 84.66 % -113.93 % 80.31 %
Operating 3 Year CFG 84.48 % -118.65 % 88.36 %
Operating 5 Year CFG 90.65 % -131.3 % -135.21 %
Operating 10 Year CFG -66.34 % 12.43 % -64 %
EPS Growth 94.31 % -114.8 % 369.77 %
EPS Diluted Growth 94.31 % -114.97 % 347.67 %
Book Value Per Share 262.76 % -6.59 % 28.16 %
Share Holder 3 Year Equity Growth Per Share -81.96 % 62.6 % 85.14 %
Share Holder 5 Year Equity Growth Per Share -88.53 % 168.85 % 200.53 %
Share Holder 10 Year Equity Growth Per Share 1340 % 1265.7 % 1039.11 %
Dividend Per Share Growth - - -
Dividend 3 Year Growth Per Share - - -
Dividend 5 Year Growth Per Share - - -
Dividend 10 Year Growth Per Share - - -
Debt Growth -7.08 % 116.42 % 95.27 %
Free Cash Flow Growth 82.67 % -124.1 % 67.46 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024
Profitability
AAPG VRTX REGN ALNY SGEN ARGX
Gross Profit Margin TTM 97.03 % 86.03 % 84.94 % 86.01 % 79.1 % 46.33 %
Return on Assets TTM -15.49 % -4.32 % 11.98 % -6.4 % -16.61 % 13.45 %
Return on Equity TTM -249.8 % -6.25 % 14.77 % -509.33 % -20.8 % 16.83 %
Return on Capital Employed TTM -25.48 % -3.89 % 11.35 % -3.68 % -21.46 % -0.5 %
Net Income Per EBT TTM 102.58 % 329.41 % 90.27 % 75.89 % 101.33 % 25990.14 %
EBT Per Ebit TTM 106.9 % 40.44 % 129.3 % 308.03 % 98.26 % -11.64 %
EBIT Per Revenue TTM -37.7 % -6.69 % 27.37 % -4.91 % -31.24 % -1.24 %
Cash Flow To Debt Ratio TTM -6.67 % -59.44 % 146.15 % -3.47 % -1043.73 % -201.37 %
Receivables Turnover TTM 9.9 6.15 2.53 5.62 3.91 2.46
Payables Turnover TTM 0.32 3.49 3.01 3.37 1.97 2.39
Inventory Turnover TTM 4.41 1.14 0.66 5.01 0.96 2.93
Fixed Asset Turnover TTM 108.26 % 421.34 % 300.07 % 337.41 % 665.41 % 4929.48 %
Asset Turnover TTM 37.46 % 48.51 % 37.52 % 55.72 % 53.41 % 35.83 %
Operating Cash Flow Per Share TTM -1.47 -3.82 37.05 -0.35 -2.46 -1.07
Free Cash Flow Per Share TTM -1.8 -4.9 28.3 -0.58 -2.88 -1.09
Cash Per Share TTM 1699.83 % 2413.86 % 7825.12 % 2024.29 % 939.52 % 4688.94 %
Operating Cash Flow Sales Ratio TTM -11.36 % -8.83 % 28.06 % -1.92 % -23.12 % -3.54 %
Free Cash Flow Operating Cash Flow Ratio TTM 121.81 % 128.33 % 76.4 % 167.11 % 117.04 % 102.26 %
Cash Flow Coverage Ratios TTM -6.67 % -59.44 % 146.15 % -3.47 % -1043.73 % -201.37 %
Price To Free Cash Flows Ratio TTM -181.87 -93.78 19.26 -574.08 -81.26 -443.33
Price To Operating Cash Flows Ratio TTM -192.85 -120.39 14.79 -954.11 -93.1 -526.76
Price Cash Flow Ratio TTM -192.85 -120.39 14.79 -954.11 -93.1 -526.76
Income Statement (TTM)
AAPG VRTX REGN ALNY SGEN ARGX
Revenue $0.98B $11.02B $14.2B $2.25B $1.96B $2.19B
Gross Profit $0.95B $9.49B $12.23B $1.92B $1.55B $1.96B
Gross Profit Ratio 97.03% 86.11% 86.13% 85.62% 79.1% 89.62%
EBITDA $-0.24B $0.49B $5.32B $-0.18B $-0.62B $0.11B
Net Income $-0.41B $-0.54B $4.41B $-0.28B $-0.61B $0.83B
EPS Diluted -0.75 -2.08 38.34 -2.16 -3.3 12.78
Balance Sheet (MRQ)
AAPG VRTX REGN ALNY SGEN ARGX
Long Term Debt $0.87B $1.66B $1.98B $0B $0.04B $0.03B
Total Liabilities $2.34B $6.12B $8.41B $4.17B $0.87B $0.7B
Total Equity $0.27B $16.41B $29.35B $0.07B $2.8B $5.5B
Total Investments $0.03B $6.65B $15.42B $1.73B $1.42B $1.93B
Total Debt $1.67B $1.75B $2.7B $1.3B $0.04B $0.04B
Total Assets $2.62B $22.53B $37.76B $4.3B $3.67B $6.2B
Cash Flow Statement (TTM)
AAPG VRTX REGN ALNY SGEN ARGX
Net Income $-0.4B $-0.54B $4.41B $-0.28B $-0.61B $-0.02B
Inventory $0.01B $-0.52B $-0.62B $0.01B $-0.23B $-0.09B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.11B $-0.49B $4.42B $-0.01B $-0.45B $-0.08B
Capital Expenditure $-0.02B $-0.3B $-0.76B $-0.03B $-0.08B $-0.07B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AARD Aardvark Therapeutics, Inc. Common Stock 11.79
ABCL AbCellera Biologics Inc. 4.47
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 6.6
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.505
ABPWW 0.0225
ABSI Absci Corporation 3.12
ABUS Arbutus Biopharma Corporation 3.125
ABVC ABVC BioPharma, Inc. 3.375
ABVX Abivax SA American Depositary Shares 9.94
ACAD ACADIA Pharmaceuticals Inc. 22.575
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.7548
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.705
ACIU AC Immune SA 2.06
ACLX Arcellx, Inc. 67.62
ETFs With Exposure to AAPG
Ticker ETF Name Weight Percentage Price
PGJ Invesco Golden Dragon China ETF 0.027 29.99
BOUT Innovator IBD Breakout Opportunities ETF 6.09 37.38
CANC Tema Oncology ETF 0.8 26.07
Unlock